Glioblastoma (GBM) is a highly aggressive type of primary brain cancer with a poor
prognosis, and despite intensive research, survival rates have not significantly improved …

Glioblastoma is a common malignant primary intracranial tumor characterized by rapid
invasive growth and a high recurrence rate after surgery. MicroRNAs (miRNAs) are involved …

MicroRNAs are a class of small non-coding RNA molecules that regulate gene expression
on post-transcriptional level. Their biogenesis consists of a complex series of sequential …

Extensive invasion and angiogenesis are hallmark features of malignant glioblastomas.
Here, we co-cultured U87 human glioblastoma cells and human microvascular endothelial …

Temozolomide (TMZ), an alkylating agent of the imidazotetrazine series, is a first-line
chemotherapeutic drug used in the clinical therapy of glioblastoma multiforme, the most …

Glioblastoma multiforme (GBM) is an aggressive and dismal disease with a median overall
survival of around 15 months and a 5-year survival rate of 7.2%. Owing to genetic mutations …

Glioblastoma multiform (GBM) is a type of aggressive brain cancer with limited success in
standard treatment. MicroRNAs are one of the most beneficial tools for diagnosis, prognosis …

Prostate cancer is the most commonly diagnosed cancer in men with African American men
disproportionally suffering from the burden of this disease. Biomarkers that could …

Endosomes and lysosomes (endolysosomes) are membrane bounded organelles that play
a key role in cell survival and cell death. These acidic intracellular organelles are the …

Background Glioblastoma (GBM) is an aggressive and malignant brain tumor with extremely
poor prognosis. Despite advances in treatment, the pathogenesis of GBM remains elusive …